Sara Onvani, MSc - Publications
Affiliations: | Laboratory Medicine and Pathobiology | University of Toronto, Toronto, ON, Canada |
Area:
brain tumor molecular biology, neural circuitryYear | Citation | Score | |||
---|---|---|---|---|---|
2012 | Onvani S, Terakawa Y, Smith C, Northcott P, Taylor M, Rutka J. Molecular genetic analysis of the hepatocyte growth factor/MET signaling pathway in pediatric medulloblastoma. Genes, Chromosomes & Cancer. 51: 675-88. PMID 22447520 DOI: 10.1002/Gcc.21954 | 0.383 | |||
2010 | Kongkham PN, Onvani S, Smith CA, Rutka JT. Inhibition of the MET Receptor Tyrosine Kinase as a Novel Therapeutic Strategy in Medulloblastoma. Translational Oncology. 3: 336-43. PMID 21151472 DOI: 10.1593/Tlo.10121 | 0.395 | |||
2010 | Onvani S, Etame AB, Smith CA, Rutka JT. Genetics of medulloblastoma: clues for novel therapies. Expert Review of Neurotherapeutics. 10: 811-23. PMID 20420498 DOI: 10.1586/Ern.10.31 | 0.388 | |||
Show low-probability matches. |